{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:04:29Z","timestamp":1785769469123,"version":"3.56.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R01MH104344-03"],"award-info":[{"award-number":["R01MH104344-03"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["UH2MH109168\u201301"],"award-info":[{"award-number":["UH2MH109168\u201301"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["R01 MH071916"],"award-info":[{"award-number":["R01 MH071916"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","award":["T32MH018399-30"],"award-info":[{"award-number":["T32MH018399-30"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veteran's Administration VISN 22 Mental Illness Research, Education, and Clinical Center"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.neuropharm.2017.07.031","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T08:00:45Z","timestamp":1501574445000},"page":"254-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species"],"prefix":"10.1016","volume":"125","author":[{"given":"Zackary A.","family":"Cope","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Kreitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-2379","authenticated-orcid":false,"given":"David A.","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6573-8792","authenticated-orcid":false,"given":"Morgane","family":"Milienne-Petiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-5776","authenticated-orcid":false,"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.07.031_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hup.596","article-title":"Effects of modafinil on cognitive and meta-cognitive performance","volume":"19","author":"Baranski","year":"2004","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00213-011-2460-8","article-title":"D(1) receptor activation improves vigilance in rats as measured by the 5-choice continuous performance test","volume":"220","author":"Barnes","year":"2012","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.neuropharm.2011.04.024","article-title":"Rats tested after a washout period from sub-chronic PCP administration exhibited impaired performance in the 5-Choice Continuous Performance Test (5C-CPT) when the attentional load was increased","volume":"62","author":"Barnes","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib4","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.euroneuro.2015.07.028","article-title":"Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review","volume":"25","author":"Battleday","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00213-003-1751-0","article-title":"Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine","volume":"174","author":"Bensadoun","year":"2004","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib6","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.npp.1301159","article-title":"Neural substrates of psychostimulant-induced arousal","volume":"31","author":"Berridge","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archpsyc.1987.01800150110013","article-title":"The use of psychostimulants in general psychiatry. A reconsideration","volume":"44","author":"Chiarello","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib8","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1007\/s00213-016-4389-4","article-title":"Premature responses in the five-choice serial reaction time task reflect rodents' temporal strategies: evidence from no-light and pharmacological challenges","volume":"233","author":"Cope","year":"2016","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","article-title":"The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade","volume":"20","author":"Ferraro","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib10","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib11","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(13)60857-0","article-title":"Treatment of bipolar disorder","volume":"381","author":"Geddes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0091-3057(86)90266-2","article-title":"Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses","volume":"25","author":"Geyer","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib13","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/1097-4679(198609)42:5<792::AID-JCLP2270420519>3.0.CO;2-8","article-title":"Performance of psychiatric inpatients and intellectually deficient individuals on a task that assesses the validity of memory complaints","volume":"42","author":"Goldberg","year":"1986","journal-title":"J.\u00a0Clin. Psychol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib14","series-title":"WCST: Computer Version-2 Research Edition Manual","author":"Heaton","year":"1993"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbr.2012.08.037","article-title":"Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice","volume":"236","author":"Henry","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib16","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jad.2013.05.020","article-title":"Inhibitory deficits in euthymic bipolar disorder patients assessed in the human behavioral pattern monitor","volume":"150","author":"Henry","year":"2013","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00213-011-2170-2","article-title":"Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm","volume":"215","author":"Henry","year":"2011","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neubiorev.2010.04.002","article-title":"Cross-species assessments of motor and exploratory behavior related to bipolar disorder","volume":"34","author":"Henry","year":"2010","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib19","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2013.03.019","article-title":"A\u00a0systematic review of psychostimulant treatment of negative symptoms of schizophrenia: challenges and therapeutic opportunities","volume":"147","author":"Lindenmayer","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1017\/S1461145713001594","article-title":"Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies","volume":"17","author":"Linssen","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.neubiorev.2012.05.009","article-title":"CNTRICS final animal model task selection: control of attention","volume":"37","author":"Lustig","year":"2013","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1124\/jpet.106.106583","article-title":"Modafinil occupies dopamine and norepinephrine transporters in\u00a0vivo and modulates the transporters and trace amine activity in\u00a0vitro","volume":"319","author":"Madras","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib24","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pscychresns.2013.01.005","article-title":"Bridging the bench to bedside gap: validation of a reverse-translated rodent continuous performance test using functional magnetic resonance imaging","volume":"212","author":"McKenna","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jad.2009.04.018","article-title":"The quantitative assessment of motor activity in mania and schizophrenia","volume":"120","author":"Minassian","year":"2010","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib26","doi-asserted-by":"crossref","first-page":"e24185","DOI":"10.1371\/journal.pone.0024185","article-title":"Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals","volume":"6","author":"Minassian","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-015-4098-4","article-title":"Amphetamine increases activity but not exploration in humans and mice","volume":"233","author":"Minassian","year":"2016","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib28","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/psyp.12201","article-title":"Modafinil augments oscillatory power in middle frequencies during rule selection","volume":"51","author":"Minzenberg","year":"2014","journal-title":"Psychophysiology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib30","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1038\/npp.2014.155","article-title":"Modafinil effects on middle-frequency oscillatory power during rule selection in schizophrenia","volume":"39","author":"Minzenberg","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/npp.2015.271","article-title":"Sustained modafinil treatment effects on control-related gamma oscillatory power in schizophrenia","volume":"41","author":"Minzenberg","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuropharm.2012.07.009","article-title":"Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers","volume":"64","author":"Muller","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00213-004-1926-3","article-title":"Effects of modafinil on working memory processes in humans","volume":"177","author":"Muller","year":"2004","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A\u00a0simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J.\u00a0Basic Clin. Pharm."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0278-5846(91)90018-V","article-title":"A\u00a0scaling approach to find order parameters quantifying the effects of dopaminergic agents on unconditioned motor activity in rats","volume":"15","author":"Paulus","year":"1991","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0166-4328(05)80262-1","article-title":"Three independent factors characterize spontaneous rat motor activity","volume":"53","author":"Paulus","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0920-9964(98)00061-9","article-title":"A\u00a0multimethod approach to assessing perseverations in schizophrenia patients","volume":"33","author":"Perry","year":"1998","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib38","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","article-title":"A\u00a0reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men","volume":"66","author":"Perry","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.jcp.0000155816.21467.25","article-title":"Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?","volume":"25","author":"Randall","year":"2005","journal-title":"J.\u00a0Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1038\/sj.npp.1301161","article-title":"Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice","volume":"31","author":"Risbrough","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S2215-0366(15)00004-8","article-title":"Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people","volume":"2","author":"Sahakian","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib42","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1037\/a0023825","article-title":"Are prescription stimulants \u201csmart pills\u201d? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals","volume":"137","author":"Smith","year":"2011","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF00176625","article-title":"Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving Guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms","volume":"345","author":"Tanganelli","year":"1992","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-002-1250-8","article-title":"Cognitive enhancing effects of modafinil in healthy volunteers","volume":"165","author":"Turner","year":"2003","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbr.2013.12.003","article-title":"Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice","volume":"261","author":"van Enkhuizen","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib47","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1017\/S1461145712001198","article-title":"Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice","volume":"16","author":"van Enkhuizen","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib48","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00213-012-2854-2","article-title":"Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania","volume":"225","author":"van Enkhuizen","year":"2013","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib49","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib50","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1176\/appi.ajp.160.11.1909","article-title":"Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD","volume":"160","author":"Volkow","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib51","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.neuroscience.2004.10.005","article-title":"Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates","volume":"130","author":"Willie","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib52","article-title":"Neurophysiological characterization of attentional performance dysfunction in schizophrenia patients in a reverse-translated task","volume":"42","author":"Young","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib53","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.biopsych.2009.12.015","article-title":"Action of modafinil\u2013increased motivation via the dopamine transporter inhibition and D1 receptors?","volume":"67","author":"Young","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib54","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/tp.2013.82","article-title":"Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice","volume":"3","author":"Young","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","article-title":"The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration","volume":"96","author":"Young","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib56","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/npp.2015.120","article-title":"GlyT-1 inhibition attenuates attentional but not learning or motivational deficits of the Sp4 hypomorphic mouse model relevant to psychiatric disorders","volume":"40","author":"Young","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib57","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/npp.2011.23","article-title":"Dopamine receptor mediation of the exploratory\/hyperactivity effects of modafinil","volume":"36","author":"Young","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib58","doi-asserted-by":"crossref","first-page":"e4227","DOI":"10.1371\/journal.pone.0004227","article-title":"The 5-choice continuous performance test: evidence for a translational test of vigilance for mice","volume":"4","author":"Young","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.07.031_bib59","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","article-title":"A\u00a0reverse-translational approach to bipolar disorder: rodent and human studies in the behavioral pattern monitor","volume":"31","author":"Young","year":"2007","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbr.2011.03.054","article-title":"The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: separating response inhibition from premature responding","volume":"222","author":"Young","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib61","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/0269881111400646","article-title":"Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania","volume":"25","author":"Young","year":"2011","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.07.031_bib62","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1038\/npp.2009.62","article-title":"Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task","volume":"34","author":"Zeeb","year":"2009","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817303623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:21:23Z","timestamp":1656069683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817303623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":62,"alternative-id":["S0028390817303623"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.031","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modafinil improves attentional performance in healthy, non-sleep deprived humans at doses not inducing hyperarousal across species","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}